Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study

Affiliations

• ¹ University Hospital Zürich, Department of Neurology, Zürich, Switzerland.
• ² University Hospital Zürich, Department of Medical Oncology and Hematology, Zürich, Switzerland.
• ³ ETOP Statistical Office, Frontier-Science Foundation Hellas, Athens, Greece.
• ⁴ University Hospital Zürich, Department of Dermatology, Zürich, Switzerland.
• ⁵ University Hospital Zürich, Department of Radiation Oncology, Zürich, Switzerland.
• ⁶ Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland.
• ⁷ University of Siena, Center for Immuno-Oncology, University Hospital of Siena, Italy.
• ⁸ Clinical Trial Unit: Phase 1 and Precision Medicine, National Cancer Institute, Regina Elena, Rome, Italy.
• ⁹ Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
• ¹⁰ Netherlands Cancer Institute, Amsterdam, the Netherlands.
• ¹¹ Royal Marsden Hospital, London, UK.
• ¹² Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
• ¹³ Kantonsspital Winterthur, Switzerland.
• ¹⁴ Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
• ¹⁵ University of Perugia, Medical Oncology Unit, Santa Maria Misericordia Hospital, Perugia, Italy.
• ¹⁶ Policlinico Umberto 1, Rome, Italy.
• ¹⁷ Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain.
• ¹⁸ ETOP Statistical Office, Frontier-Science Foundation Hellas, Athens, Greece; National and Kapodistrian University of Athens, Athens, Greece.
• ¹⁹ CHUV, Lausanne, Switzerland.